This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tallant, E. A. Articles by Ferrario, C. M. Search for Related Content PubMed PubMed Citation Articles by Tallant, E. A. Articles by Ferrario, C. M.

Hypertension, Vol 18, 32-39, Copyright © 1991 by American Heart Association

ARTICLES

Human astrocytes contain two distinct angiotensin receptor subtypes

EA Tallant, N Jaiswal, DI Diz and CM Ferrario
Department of Brain and Vascular Research, The Cleveland Clinic Foundation, OH 44195-5286.

The ability of angiotensin peptides to stimulate prostaglandin release and raise intracellular calcium levels by activating a phosphoinositide- specific phospholipase C was assessed in three human astrocytoma cell lines (CRTG3, STTG1, and WITG2). The addition of angiotensin II to CRTG3 cells resulted in a dose-dependent release of prostaglandin E2 and prostacyclin, the production of inositol 1,4,5-trisphosphate, and the mobilization of intracellular calcium. Angiotensin-(1-7), previously considered to be an inactive metabolite of angiotensin II, was as potent as angiotensin II for prostaglandin release but did not activate phospholipase C or mobilize intracellular calcium. In contrast, angiotensin-(2-8) caused only a slight increase in prostaglandin release, even though it was as effective as angiotensin II in augmenting inositol 1,4,5-trisphosphate production and calcium mobilization. Moreover, neither the release of prostaglandins in response to angiotensin II or angiotensin-(1-7) nor the mobilization of intracellular calcium in response to angiotensin II required extracellular calcium. Angiotensin II and angiotensin-(1-7) caused the release of prostaglandins from all three human astrocytoma cell lines, but changes in the level of intracellular calcium in response to angiotensin II only occurred in CRTG3 cells. Although previous studies have provided evidence for angiotensin receptor subtypes on the basis of selectivity of antagonists or signal transduction mechanisms, these data suggest that human astrocytes contain multiple angiotensin receptor subtypes on the basis of their response to different angiotensin heptapeptides--angiotensin-(1-7) and angiotensin-(2- 8).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. Anton and K. B. Brosnihan Review: Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 349 - 362. [Abstract] [PDF]

				E. A. Tallant, D. I. Diz, and C. M. Ferrario Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle Hypertension, October 1, 1999; 34(4): 950 - 957. [Abstract] [Full Text] [PDF]

				A. VERKHRATSKY, R. K. ORKAND, and H. KETTENMANN Glial Calcium: Homeostasis and Signaling Function Physiol Rev, January 1, 1998; 78(1): 99 - 141. [Abstract] [Full Text] [PDF]

				E. J. Freeman, M. L. Ruehr, and R. V. Dorman ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells Am J Physiol Cell Physiol, January 1, 1998; 274(1): C282 - C288. [Abstract] [Full Text] [PDF]

				C. M. Ferrario, M. C. Chappell, E. A. Tallant, K. B. Brosnihan, and D. I. Diz Counterregulatory Actions of Angiotensin-(1-7) Hypertension, September 1, 1997; 30(3): 535 - 541. [Abstract] [Full Text]

				E. A. Tallant, X. Lu, R. B. Weiss, M. C. Chappell, and C. M. Ferrario Bovine Aortic Endothelial Cells Contain an Angiotensin-(1-7) Receptor Hypertension, January 1, 1997; 29(1): 388 - 392. [Abstract] [Full Text] [PDF]

				D. I. Diz, B. Falgui, S. M. Bosch, B. M. Westwood, J. Kent, D. Ganten, and C. M. Ferrario Hypothalamic Substance P Release: Attenuated Angiotensin Responses in mRen2(27) Transgenic Rats Hypertension, January 1, 1997; 29(1): 510 - 513. [Abstract] [Full Text] [PDF]

				E. J. Freeman, G. M. Chisolm, C. M. Ferrario, and E. A. Tallant Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth Hypertension, July 1, 1996; 28(1): 104 - 108. [Abstract] [Full Text]

				A. Moriguchi, E. A. Tallant, K. Matsumura, T. M. Reilly, H. Walton, D. Ganten, and C. M. Ferrario Opposing Actions of Angiotensin-(1-7) and Angiotensin II in the Brain of Transgenic Hypertensive Rats Hypertension, June 1, 1995; 25(6): 1260 - 1265. [Abstract] [Full Text]